Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence

Since the 2019 novel coronavirus disease (COVID-19) outbreak in 2019 and the pandemic continues for more than one year, a vast amount of drug research has been conducted and few of them got FDA approval. Our objective is to prioritize repurposable drugs using a pipeline that systematically integrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Kanglin, Wang, Yinyin, Chen, Luyao, Zhao, Zhongming, Savitz, Sean, Jiang, Xiaoqian, Tang, Jing, Kim, Yejin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632883/
https://www.ncbi.nlm.nih.gov/pubmed/34848761
http://dx.doi.org/10.1038/s41598-021-02353-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632883/
https://www.ncbi.nlm.nih.gov/pubmed/34848761
http://dx.doi.org/10.1038/s41598-021-02353-5

Ejemplares similares